Cysteine's Dual Role in T Cells: A New Avenue for Immune Modulation
A research team from Johns Hopkins University has identified how the nutrient cysteine influences CD8+ T cells, revealing its role in regulating both their proliferation and their ability to eliminate cancer cells. Published on March 31 in the journal Cell, the findings demonstrate that cysteine is processed through distinct internal pathways within T cells, impacting immune function and potentially offering new avenues for therapeutic modulation in cancer and other diseases.
Cysteine's Competing Pathways in T Cells
The study found that cysteine, an amino acid, is fundamental for CD8+ T cells but is utilized in two competing ways. Upon entering a T cell, cysteine is divided between separate internal pathways. One pathway supports cell growth and proliferation, while the other governs immune activity, including the production of molecules involved in fighting cancer.
Researchers determined that cysteine fuels the production of the antioxidant glutathione, which plays a role in regulating T-cell activity. Concurrently, it provides sulfur for iron-sulfur (FeS) clusters. These clusters, formed with the assistance of the enzyme NFS1, are crucial for T-cell multiplication and for sustaining their anti-cancer function.
"Understanding these distinct fates of cysteine within the cell is important for determining T-cell behavior," according to senior author Erika Pearce.
Experimental Findings
Laboratory and animal models were used to investigate cysteine's impact:
- Cysteine Restriction: When cysteine supply was restricted in laboratory models, T cells showed increased activity and produced higher levels of immune-signaling molecules, which enhanced their cancer-killing function. However, these cells simultaneously lost their ability to divide.
- FeS Cluster Disruption: Disrupting the formation of FeS clusters impaired T-cell expansion and weakened anti-tumor immunity.
- Mouse Melanoma Models:
- T cells lacking NFS1 exhibited reduced tumor control and signs of exhaustion in mouse models of melanoma skin cancer.
- Conversely, enhancing NFS1 activity improved both T-cell proliferation and tumor control.
- Blocking glutathione production after initial T-cell activation was observed to strengthen anti-tumor responses.
Implications for Immune Modulation
These discoveries suggest a previously unrecognized level of metabolic control over immune cell function. The findings indicate the potential to selectively modulate how cysteine is used within T cells. Researchers propose that this could involve boosting its use in certain pathways while inhibiting it in others, aiming to support cancer-fighting immune responses and limit processes that suppress immune activity or lead to T-cell exhaustion.
While further research is required, this understanding provides new opportunities to fine-tune T-cell responses, potentially informing strategies for cancer and other diseases.